Effect of Erenumab Versus Migraine Preventive Medications on Cardiovascular and Cerebrovascular Outcomes

被引：0
|
作者：
Dodick, D. [1 ]
Ailani, J. [2 ]
Oh, S. [3 ]
Kent, S. [3 ]
Gill, K. [3 ]
Fu, A. [3 ]
Urman, R. [3 ]
Khodavirdi, A. [3 ]
Pannacciulli, N. [3 ]
Tepper, S. [4 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
[2] MedStar Georgetown Univ Hosp, Dept Neurol, Washington, DC USA
[3] Amgen Inc, 1 Amgen Ctr Dr, Thousand Oaks, CA USA
[4] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IO-04
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [1] Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study
    Dodick, David W.
    Tepper, Stewart J.
    Ailani, Jessica
    Khodavirdi, Ani C.
    Pannacciulli, Nico
    Fu, Alan
    Kent, Shia T.
    Gill, Karminder
    Urman, Robert
    Oh, Sam S.
    HEADACHE, 2025,
  • [2] Comparative Effectiveness of Erenumab versus Oral Preventive Medications among Migraine Patients: A US Claims Database Study
    Tepper, Stewart
    Fang, Juanzhi
    Zhou, Lujia
    Vo, Pamela
    Abdrabboh, Ahmad
    Glassberg, Mrudula
    Ferraris, Matias
    NEUROLOGY, 2021, 96 (15)
  • [3] Migraine preventive medications: a reappraisal
    Adelman, JU
    Brod, A
    Von Seggern, RL
    Mannix, LK
    Rapoport, AM
    CEPHALALGIA, 1998, 18 (09) : 605 - 611
  • [4] Safety and tolerability evaluation of erenumab for the preventive treatment of migraine
    Deligianni, Christina, I
    Mitsikostas, Dimos D.
    Ashina, Messoud
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (08) : 867 - 876
  • [5] Cardiovascular Safety of Erenumab in Patients with Migraine and Aura
    Ashina, M.
    Goadsby, P. J.
    Dodick, D. W.
    Tepper, S. J.
    Xue, F.
    Zhang, F.
    Olearczyk, J. J.
    Lima, Paiva da Silva G.
    HEADACHE, 2020, 60 : 101 - 102
  • [6] Cardiovascular Safety of Erenumab in Patients with Migraine and Aura
    Ashina, Messoud
    Goadsby, Peter
    Dodick, David
    Tepper, Stewart
    Xue, Fei
    Zhang, Feng
    Olearczyk, Jeffrey
    Lima, Gabriel Paiva da Silva
    NEUROLOGY, 2020, 94 (15)
  • [7] SIZING OF THE MIGRAINE POPULATION TREATED WITH PREVENTIVE MEDICATIONS FOR MIGRAINE
    Burrell, E. R.
    Mues, K. E.
    Xue, F.
    Buse, D. C.
    Lipton, R. B.
    Chia, V. M.
    VALUE IN HEALTH, 2018, 21 : S204 - S204
  • [8] Evaluation of ischemic cardiovascular and cerebrovascular adverse events by 10-year cardiovascular risk score in patients with migraine treated with erenumab
    Kudrow, D.
    Starling, A. J.
    Ailani, J.
    Dafer, R. M.
    Zhang, F.
    Xue, F.
    Patel, N.
    Nelson, R.
    HEADACHE, 2021, 61 : 127 - 127
  • [9] Serum CGRP in migraine patients using erenumab as preventive treatment
    Lentsch, Simone de Vries
    Garrelds, Ingrid M.
    Danser, A. H. Jan
    Terwindt, Gisela M.
    MaassenVanDenBrink, Antoinette
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [10] Serum CGRP in migraine patients using erenumab as preventive treatment
    Simone de Vries Lentsch
    Ingrid M. Garrelds
    A. H. Jan Danser
    Gisela M. Terwindt
    Antoinette MaassenVanDenBrink
    The Journal of Headache and Pain, 2022, 23
12345